Skip to main content

ResMed| United States revenue

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026 · Market value $33.91B

United States revenue at ResMed| came to $3.6B for the fiscal year to 30 Jun 2026, up 8.4% from a year earlier.

As ResMed| reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 13 Aug 2026.

By fiscal year

$904.3MJun 2015$1.1BJun 2016$1.2BJun 2017$1.3BJun 2018$1.6BJun 2019$1.8BJun 2020$2.0BJun 2021$2.2BJun 2022$2.7BJun 2023$3.0BJun 2024$3.3BJun 2025$3.6BJun 2026
ResMed| United States revenue, every reported period
Period endingUnited States revenueChange on a yearFiled
30 Jun 2026$3.6Bup 8.4%13 Aug 2026
30 Jun 2025$3.3Bup 10.3%8 Aug 2025
30 Jun 2024$3.0Bup 9.6%9 Aug 2024
30 Jun 2023$2.7Bup 20.9%11 Aug 2023
30 Jun 2022$2.2Bup 14.6%12 Aug 2022
30 Jun 2021$2.0Bup 7.3%17 Aug 2021
30 Jun 2020$1.8Bup 15.1%13 Aug 2020
30 Jun 2019$1.6Bup 18.1%8 Aug 2019
30 Jun 2018$1.3Bup 9.4%17 Aug 2018
30 Jun 2017$1.2Bup 16.4%4 Aug 2017
30 Jun 2016$1.1Bup 16.8%5 Aug 2016
30 Jun 2015$904.3M—7 Aug 2015

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of ResMed|: Devices revenue · Masks and other revenue · Residential Care Software revenue · Rest of the World revenue · Global revenue · U.S., Canada and Latin America revenue · Combined Europe, Asia and other markets revenue · financial statements

Every KPI and segment of RMD, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.